cefuroxim fresenius kabi 750 mg inj./inf. sol. (pwdr.) i.v./i.m. vial
fresenius kabi sa-nv - cefuroxime sodium 789 mg - eq. cefuroxime 750 mg - powder for solution for injection/infusion - 750 mg - cefuroxime sodium 789 mg - cefuroxime
cefuroxim fresenius kabi 1 500 mg inj. sol. (pwdr.) i.v./i.m. vial
fresenius kabi sa-nv - cefuroxime sodium 1578 mg - eq. cefuroxime 1500 mg - powder for solution for injection - 1500 mg - cefuroxime sodium 1578 mg - cefuroxime
cefuroxim helm 50 mg inj. sol. (pwdr.) vial
helm ag - cefuroxime sodium 52,6 mg - eq. cefuroxime 50 mg - powder for solution for injection - 50 mg - cefuroxime sodium 52.6 mg - cefuroxime
cefuroxime medo 750 mg
a.l. medi-market ltd. - cefuroxime as sodium - powder for solution for inj/inf - cefuroxime as sodium 750 mg/vial - cefuroxime - cefuroxime medo is indicated for the treatment of the infections listed below in adults and children, including neonates (from birth)• community acquired pneumonia• acute exacerbations of chronic bronchitis• complicated urinary tract infections, including pyelonephritis• soft-tissue infections: cellulitis, erysipelas and wound infections• intra-abdominal infections • prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular, and gynaecological surgery (including caesarean section) • nose infections for example, sinusitis • septic arthritis
cefuroxime 250mg powder for solution for injection vials
bowmed ibisqus ltd - cefuroxime sodium - powder for solution for injection - 250mg
cefuroxime stravencon 1500 mg inj./inf. sol. (pwdr.) i.m./i.v. vial
stravencon ltd. - cefuroxime sodium - eq. cefuroxime 1500 mg - powder for solution for injection/infusion - 1500 mg - cefuroxime sodium - cefuroxime
exime 750 injection
pro med pharmacuticals ltd p.o box 22953-00100 nairobi. - cefuroxime sodium - injection - each vial contain cefuroxime sodium usp 750 mg - cefuroxime
cefuroxime be pharma 750 mg
a.l. medi-market ltd. - cefuroxime as sodium - powder for solution or suspension for injection or infusion - cefuroxime as sodium 750 mg/vial - cefuroxime - cefuroxime be pharma 750 mg is indicated for the treatment of the infections listed below in adults and children, including neonates (from birth)•community acquired pneumonia•acute exacerbations of chronic bronchitis•complicated urinary tract infections, including pyelonephritis•soft-tissue infections: cellulitis, erysipelas and wound infections•intra-abdominal infections•prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular, and gynaecological surgery (including caesarean section)•nose infections for example, sinusitis•septic arthritis
furox - 750 injection
zawadi healthcare ltd p.o.box 14629 - 00800, maua close,westlands, - cefuroxime - injection - 750 mg - cefuroxime
cefuroxime axetil actavis 250mg film coated tablets
actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - cefuroxime - film-coated tablet - cefuroxime 250 mg - antibacterials for systemic use